Sentences with phrase «other pharma companies»

They started by looking at how other pharma companies were using Social Media.

It's possible that Paulson and Vanguard decided to invest their gains into other pharma companies developing new drugs, but they are just as likely to put their money somewhere else.

Not exact matches

Shkreli originally became infamous for his other former company Turing Pharma's 5,000 % price hike for a drug used by cancer and AIDS patients.

Others, such as consumer watchdog Public Citizen and the preventive medicine advocacy group Trust for America's Health (TFAH), had very different takes, arguing Cures mostly benefits pharma companies at the expense of other important public health initiatives.

Food and Drug Administration Commissioner Scott Gottlieb decried what he called a «Kabuki» drug pricing construct between pharma companies, pharmacy benefits managers, insurers, and others during a health insurance conference.

By printing multiple lung airways — or any other afflicted organ — from a human patient and testing drugs on them, pharma companies can bypass the ethically challenged practice of testing on animals and proceed to human clinical trials with greater confidence the drugs will actually work, according to Wadsworth.

Consider also a company like Horizon Pharma (HZNP), a biopharmaceutical firm that has acquired three other pharma firms since September ofPharma (HZNP), a biopharmaceutical firm that has acquired three other pharma firms since September ofpharma firms since September of 2014.

Immuno - oncolocy has been the focus of Big Pharma and biotechs alike, with companies such as Merck (mrk), Bristol - Myers Squibb (bmy), Pfizer (pfe), Roche / Genentech, Juno (juno), Kite Pharma (kite), Novartis (nvs), and countless others pouring massive investments into the space (the Loncar ETF contains almost all of these companies).

Fortune Brainstorm Health, in association with IBM Watson Health, gathers not only C - suite leaders of top companies, hospitals, insurers, and cutting - edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care.

Suffolk County is suing Connecticut - based Purdue Pharma along with a number of other pharmaceutical companies for deceptive practices that it claims led to the county's opioid and heroin epidemic.

But in the world of big pharma, Gervais warns, not all other companies encourage publishing and may take a more defensive position regarding the release of information.

For example, @JoinAstraZeneca and other big pharma companies tweet job openings to their followers daily.

Creating new opportunities for «all of these very talented, experienced, displaced workers» requires «getting them thinking creatively about maybe making the move from big pharma, where they've spent their careers,» to other opportunities, such as smaller, newer companies created by themselves, perhaps, or other displaced scientists.

Like other big pharma companies, Pfizer is partnering with academic institutions to share the risk of drug development and take advantage of academic scientists» broad base of knowledge, says Boston - based Anthony Coyle, vice president of the Centers for Therapeutic Innovation (CTI) at Pfizer.

Pharma companies would favor investigations into drugs» effects, he said, but asked that drug producers and other stakeholders be included in decision - making.

They have joined forces with CHS Pharma, Inc., a South Florida - based biotechnology development company that has an intellectual property portfolio for potential treatments related to ischemic stroke, dry macular degeneration as well as other age - related disorders such as Alzheimer's disease, to further develop and commercialize this promising technology.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions

The other techniques most used by pharma and biotech companies are small / wide and ultra-small angle X-ray scattering, pair distribution function (PDF), micro - and nano - 3D tomography and X-ray fluorescence and powder diffraction.

At the same time that Purdue and other big pharma companies were hosting symposia, they doubled their sales force and gave doctors 30 - day free coupons so they could let patients try these drugs for pain that previously wasn't managed using opiates.

The group also cited the Massachusetts Life Sciences Center — which provides tax incentives and other support for biotech and pharma companies — as a positive example.

1 Axis Long Term Equity Direct - G 2 Birla SL Frontline Equity - G 3 Birla SL MNC - G 4 Birla SL Top 100 - G 5 Canara Robeco Equity Diversified Reg - D 6 DSPBR Micro Cap Reg - G 7 DSPBR Top 100 Equity Reg - D 8 Franklin India Bluechip - D 9 Franklin India Bluechip - G 10 Franklin India Feeder Franklin US Opp - G 11 Franklin India Prima - G 12 Franklin India Smaller Companies - G 13 HDFC Childrens Gift Inv 14 HDFC Mid-Cap Opportunities - G 15 ICICI Pru Banking and Financial Services - G 16 ICICI Pru Dynamic - G 17 ICICI Pru Exports and Other Services - G 18 ICICI Pru FMCG - G 19 ICICI Pru Focused Bluechip Equity - G 20 ICICI Pru Technology - G 21 ICICI Pru Top 100 - G 22 ICICI Pru Value Discovery - G 23 IDFC Premier Equity Reg - G 24 Invesco India Mid N Small Cap - G 25 Reliance Equity Opportunities - G 26 Reliance Gold Savings - D 27 Reliance Pharma - G 28 Reliance Tax Saver - G 29 SBI Emerging Businesses - G 30 SBI FMCG - G 31 SBI Magnum Global - G 32 SBI Magnum Midcap - G 33 SBI Pharma - G 34 Sundaram S.M.I.L.E. Reg - G 35 Tata Dividend Yield Reg - G 36 Tata Equity PE Dividend Trigger B Reg - D 37 Tata Ethical Reg - G 38 UTI Mid Cap - G 39 UTI MNC - G 40 UTI Opportunities - G

Similarly, biomedical and pharmaceutical research is bedazzled by molecular genetics, has sequenced the genome of one or two humans and a handful of other species and invested trillions on very rigidly reductionistic bottom - up research into medicines and diseases — with the result of empty drug pipelines for the big pharma companies in spite of all this investment.

It is the clear responsibility of Pharmaceutical companies such as Gallant Pharma to put the health and safety of the patients above any other interests.

Pharma companies are reaching their hands out to each other, with new collaborations in HIV and cancer drugs announced this week.

One side (big pharma, insurance companies, hospital systems) has more leverage — information, resources, influence, negotiation power — than the other.

The pharma industry has reacted with some companies shifting their trials to other Asian nations, such as China, Singapore and South Korea.

Whether those people are the doctors and other healthcare providers they serve, or their managers and colleagues at top pharma companies, working with great people is what makes pharma jobs great.